Garry Pairaudeau
Technik-/Wissenschafts-/F&E-Leiter bei Exscientia AI Ltd.
Aktive Positionen von Garry Pairaudeau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 | - |
Karriereverlauf von Garry Pairaudeau
Ehemalige bekannte Positionen von Garry Pairaudeau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EXSCIENTIA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 | 30.06.2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2014 | 01.11.2020 |
Ausbildung von Garry Pairaudeau
| The University of Southampton | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Garry Pairaudeau
- Erfahrung
